Homocysteine Serum Levels in Diabetic Patients with Non Proliferative, Proliferative and without Retinopathy | Zendy

Giulia Malaguarnera | Zendy; Caterina Gagliano | Zendy; Maria Giordano | Zendy; Salvatore Salomone | Zendy; Marco Vacante | Zendy; Claudio Bucolo | Zendy; Filippo Caraci | Zendy; Michele Reibaldi | Zendy; Filippo Drago | Zendy; Teresio Avitabile | Zendy; Massimo Motta | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Homocysteine Serum Levels in Diabetic Patients with Non Proliferative, Proliferative and without Retinopathy

Author(s) -

Giulia Malaguarnera,

Caterina Gagliano,

Maria Giordano,

Salvatore Salomone,

Marco Vacante,

Claudio Bucolo,

Filippo Caraci,

Michele Reibaldi,

Filippo Drago,

Teresio Avitabile,

Massimo Motta

Publication year - 2014

Publication title -

biomed research international

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.772

H-Index - 126

eISSN - 2314-6141

pISSN - 2314-6133

DOI - 10.1155/2014/191497

Subject(s) - diabetic retinopathy , homocysteine , medicine , plasma homocysteine , diabetes mellitus , retinopathy , complication , type 2 diabetes mellitus , endocrinology , ophthalmology , gastroenterology

Homocysteine has been associated with extracellular matrix changes. The diabetic retinopathy is a neurovascular complication of diabetes mellitus and it is the leading cause of vision loss among working adults worldwide. In this study, we evaluate the role of homocysteine in diabetic retinopathy analyzing the plasma levels of homocysteine in 63 diabetic type 2 patients with nonproliferative retinopathy (NPDR), 62 patients with proliferative diabetic retinopathy (PDR), 50 healthy subjects used as control group, and 75 randomly selected patients.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research